ClassID:

96128

C07F9/65031 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms; Five-membered rings having the nitrogen atoms in the positions 1 and 2

Sub-classes:
Recent Application in this class:
#1
20260035360
2026-02-05

INHIBITORS OF MYC AND USES THEREOF

#2
20250296920
2025-09-25

FORMULATIONS COMPRISING N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDE COMPOUNDS AND USES THEREOF

#3
20250263398
2025-08-21

PROCESS

#4
20250115579
2025-04-10

QUINOLINE cGAS ANTAGONIST COMPOUNDS

#5
20240279220
2024-08-22

INDOLE COMPOUNDS AND METHODS OF USE

#6
20240262794
2024-08-08

COMPOUNDS FOR TREATING CONDITIONS RELATED TO OXIDATIVE STRESS

#7
20240109924
2024-04-04

IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS

#8
20240092760
2024-03-21

Quinoline cGAS antagonist compounds

#9
20240018174
2024-01-18

QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION

#10
20230227437
2023-07-20

IMMUNOMODULATOR

#11
20230081291
2023-03-16

Quinoline cGAS antagonist compounds

#12
20220331346
2022-10-20

Substituted bicyclic compounds

#13
20220220134
2022-07-14

Phosphohistidine mimetics and antibodies to same

#14
20220041633
2022-02-10

Quinone methide analog signal amplification

#15
20210155576
2021-05-27

Neprilysin inhibitors

#16
20210002233
2021-01-07

PKM2 MODULATORS AND METHODS FOR THEIR USE

#17
20200281952
2020-09-10

Substituted bicyclic compounds

#18
20200165279
2020-05-28

Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma

#19
20200109120
2020-04-09

PKM2 modulators and methods for their use

#20
20200017436
2020-01-16

Neprilysin inhibitors

#21
20190330155
2019-10-31

Kinase inhibitors

#22
20190128893
2019-05-02

Quinone methide analog signal amplification

#23
20190127405
2019-05-02

Quinone methide analog signal amplification

#24
20190119219
2019-04-25

PKM2 modulators and methods for their use

#25
20190092796
2019-03-28

PHOSPHOHISTIDINE MIMETICS AND ANTIBODIES TO SAME

#26
20190076450
2019-03-14

Substituted bicyclic compounds

#27
20180327350
2018-11-15

Neprilysin inhibitors

#28
20180319748
2018-11-08

Kinase inhibitors

#29
20170360811
2017-12-21

Bisphosphonic acid derivative and application for same

#30
20170355664
2017-12-14

Neprilysin inhibitors

#31
20170304332
2017-10-26

Substituted bicyclic compounds

#32
20170042917
2017-02-16

Substituted bicyclic compounds

#33
20170015631
2017-01-19

PKM2 modulators and methods for their use

#34
20160340375
2016-11-24

Kinase inhibitors

#35
20160137677
2016-05-19

Formylpyrrole-based heterocycles for nucleic acid attachment to supports

#36
20160052888
2016-02-25

Substituted bicyclic compounds

#37
20160002148
2016-01-07

Neprilysin inhibitors

#38
20150031833
2015-01-29

Formylpyrrole-based heterocycles for nucleic acid attachment to supports

#39
20130330366
2013-12-12

Neprilysin inhibitors

#40
20130115593
2013-05-09

Substrates for chromogenic detection and methods of use in detection assays and kits

#41
20120208784
2012-08-16

Substituted propane phosphinic acid derivatives

#42
20120157414
2012-06-21

Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#43
20120142636
2012-06-07

Substituted pyrazolylamides useful as glucokinase activators

#44
20120022252
2012-01-26

Phosphine ligands for catalytic reactions

#45
20110294758
2011-12-01

Activators of glucokinase

#46
20110288053
2011-11-24

ANTIVIRAL PHOSPHONATE ANALOGS

#47
20110118211
2011-05-19

Substituted pyrazolylamide compounds useful as glucokinase activators

#48
20100144791
2010-06-10

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

#49
20100041895
2010-02-18

Synthesis and stabilization of neutral compounds with homonuclear bonds

#50
20100009936
2010-01-14

CHEMICAL COMPOUNDS

#51
20090286758
2009-11-19

Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity

#52
20090275535
2009-11-05

Antiviral phosphonate analogs

#53
20090270351
2009-10-29

Phosphorus derivatives as histone deacetylase inhibitors

#54
20090247488
2009-10-01

ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS

#55
20090069568
2009-03-12

Method for producing indazol-3-ylmethyl phosphonium salt

#56
20080306264
2008-12-11

Cycloolefin phosphine ligands and their use in catalysis

#57
20080287438
2008-11-20

Agent for preventing or treating neuropathy

#58
20080221335
2008-09-11

Method for the manufacture of substituted phosphanes, and substituted phosphanes manufactured according to said method

#59
20080096938
2008-04-24

Sphingosine-1-phosphate (SIP) receptor agonists

#60
20080064662
2008-03-13

Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity

#61
20080027118
2008-01-31

Prodrugs of mitotic kinesin inhibitors

#62
20080009465
2008-01-10

Phosphonate and phosphinate pyrazolylamide glucokinase activators

#63
20070213302
2007-09-13

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

#64
20070060502
2007-03-15

Substituted propane phosphinic acid derivatives

#65
20070049761
2007-03-01

Substituted phosphonate fluorescent sensors and use thereof

#66
20060275636
2006-12-07

Fuel cell membrane containing zirconium phosphate

#67
20060223866
2006-10-05

Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity

#68
20060199788
2006-09-07

Anti-inflammatory phosphonate compounds

#69
20060135786
2006-06-22

Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity

#70
20060111326
2006-05-25

Phosphoramide derivatives

#71
20060004069
2006-01-05

Agent for preventing or treating neuropathy

#72
20050256078
2005-11-17

Inosine monophosphate dehydrogenase inhibitory phosphonate compounds

#73
20050234020
2005-10-20

Thrombopoietin mimetics

#74
20050215513
2005-09-29

Antiviral phosphonate analogs